Global Motion Sickness Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	169 Pages	TechNavio	June, 2024	INF19007127

Best Price Guarantee
Price	from $2,500
Length	169 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19007127

Global Motion Sickness Drugs Market 2024-2028

The motion sickness drugs market is forecasted to grow by USD 139.5 mn during 2023-2028, accelerating at a CAGR of 4.37% during the forecast period. The report on the motion sickness drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of over-the-counter (otc) drugs, availability of motion sickness drugs in multiple dosage forms, and growing travel and tourism worldwide.

Technavio's motion sickness drugs market is segmented as below:

By Product

Antihistamines
Anticholinergics

By Distribution Channel

Offline
Online

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of nauseogenic information technology as one of the prime reasons driving the motion sickness drugs market growth during the next few years. Also, increased penetration of online channels and growing research on psychosomatic disorders will lead to sizable demand in the market.

The report on the motion sickness drugs market covers the following areas:

Motion sickness drugs market sizing
Motion sickness drugs market forecast
Motion sickness drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading motion sickness drugs market vendors that include Abbott Laboratories, Amneal Pharmaceuticals Inc., Baxter International Inc., CVS Health Corp., DM Pharma Marketing Pvt. Ltd., GlaxoSmithKline Plc, Hylands, Lupin Ltd., Merck KGaA, Myungmoon Pharm Co. Ltd., Novartis AG, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Tivic Health Systems Inc., Viatris Inc., WellSpring Pharmaceutical Corp., Zenomed Healthcare Pvt. Ltd., and Zydus Lifesciences Ltd.. Also, the motion sickness drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Motion Sickness Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Motion Sickness Drugs Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Distribution Channel segment analysis 2018 - 2022; Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Antihistamines - Market size and forecast 2023-2028; Chart on Antihistamines - Market size and forecast 2023-2028 ($ million); Data Table on Antihistamines - Market size and forecast 2023-2028 ($ million); Chart on Antihistamines - Year-over-year growth 2023-2028 (%); Data Table on Antihistamines - Year-over-year growth 2023-2028 (%); 6.4 Anticholinergics - Market size and forecast 2023-2028; Chart on Anticholinergics - Market size and forecast 2023-2028 ($ million); Data Table on Anticholinergics - Market size and forecast 2023-2028 ($ million); Chart on Anticholinergics - Year-over-year growth 2023-2028 (%); Data Table on Anticholinergics - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Distribution Channel: 7.1 Market segments; Chart on Distribution Channel - Market share 2023-2028 (%); Data Table on Distribution Channel - Market share 2023-2028 (%); 7.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 7.3 Offline - Market size and forecast 2023-2028; Chart on Offline - Market size and forecast 2023-2028 ($ million); Data Table on Offline - Market size and forecast 2023-2028 ($ million); Chart on Offline - Year-over-year growth 2023-2028 (%); Data Table on Offline - Year-over-year growth 2023-2028 (%); 7.4 Online - Market size and forecast 2023-2028; Chart on Online - Market size and forecast 2023-2028 ($ million); Data Table on Online - Market size and forecast 2023-2028 ($ million); Chart on Online - Year-over-year growth 2023-2028 (%); Data Table on Online - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share by geography 2023-2028 (%); Data Table on Market share by geography 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity by geography; Market opportunity by geography ($ million); Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 Amneal Pharmaceuticals Inc.; Amneal Pharmaceuticals Inc. - Overview; Amneal Pharmaceuticals Inc. - Business segments; Amneal Pharmaceuticals Inc. - Key news; Amneal Pharmaceuticals Inc. - Key offerings; Amneal Pharmaceuticals Inc. - Segment focus; 12.5 Baxter International Inc.; Baxter International Inc. - Overview; Baxter International Inc. - Business segments; Baxter International Inc. - Key news; Baxter International Inc. - Key offerings; Baxter International Inc. - Segment focus; 12.6 CVS Health Corp.; CVS Health Corp. - Overview; CVS Health Corp. - Business segments; CVS Health Corp. - Key offerings; CVS Health Corp. - Segment focus; 12.7 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.8 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Product / Service; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; 12.9 Myungmoon Pharm Co. Ltd.; Myungmoon Pharm Co. Ltd. - Overview; Myungmoon Pharm Co. Ltd. - Product / Service; Myungmoon Pharm Co. Ltd. - Key offerings; 12.10 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.11 Perrigo Co. Plc; Perrigo Co. Plc - Overview; Perrigo Co. Plc - Business segments; Perrigo Co. Plc - Key offerings; Perrigo Co. Plc - Segment focus; 12.12 Prestige Consumer Healthcare Inc.; Prestige Consumer Healthcare Inc. - Overview; Prestige Consumer Healthcare Inc. - Business segments; Prestige Consumer Healthcare Inc. - Key offerings; Prestige Consumer Healthcare Inc. - Segment focus; 12.13 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; 12.14 Tivic Health Systems Inc.; Tivic Health Systems Inc. - Overview; Tivic Health Systems Inc. - Product / Service; Tivic Health Systems Inc. - Key offerings; 12.15 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus; 12.16 WellSpring Pharmaceutical Corp.; WellSpring Pharmaceutical Corp. - Overview; WellSpring Pharmaceutical Corp. - Product / Service; WellSpring Pharmaceutical Corp. - Key offerings; 12.17 Zydus Lifesciences Ltd.; Zydus Lifesciences Ltd. - Overview; Zydus Lifesciences Ltd. - Business segments; Zydus Lifesciences Ltd. - Key news; Zydus Lifesciences Ltd. - Key offerings; Zydus Lifesciences Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Motion Sickness Drugs Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on Antihistamines - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Antihistamines - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Antihistamines - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Antihistamines - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Anticholinergics - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Anticholinergics - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Anticholinergics - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Anticholinergics - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Product ($ million); Exhibits45: Data Table on Market opportunity by Product ($ million); Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Distribution Channel; Exhibits49: Data Table on Comparison by Distribution Channel; Exhibits50: Chart on Offline - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Offline - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Offline - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Offline - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Online - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Online - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Online - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Online - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Distribution Channel ($ million); Exhibits59: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share by geography 2023-2028 (%); Exhibits62: Data Table on Market share by geography 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity by geography ($ million); Exhibits102: Data Tables on Market opportunity by geography ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: Abbott Laboratories - Overview; Exhibits110: Abbott Laboratories - Business segments; Exhibits111: Abbott Laboratories - Key news; Exhibits112: Abbott Laboratories - Key offerings; Exhibits113: Abbott Laboratories - Segment focus; Exhibits114: Amneal Pharmaceuticals Inc. - Overview; Exhibits115: Amneal Pharmaceuticals Inc. - Business segments; Exhibits116: Amneal Pharmaceuticals Inc. - Key news; Exhibits117: Amneal Pharmaceuticals Inc. - Key offerings; Exhibits118: Amneal Pharmaceuticals Inc. - Segment focus; Exhibits119: Baxter International Inc. - Overview; Exhibits120: Baxter International Inc. - Business segments; Exhibits121: Baxter International Inc. - Key news; Exhibits122: Baxter International Inc. - Key offerings; Exhibits123: Baxter International Inc. - Segment focus; Exhibits124: CVS Health Corp. - Overview; Exhibits125: CVS Health Corp. - Business segments; Exhibits126: CVS Health Corp. - Key offerings; Exhibits127: CVS Health Corp. - Segment focus; Exhibits128: GlaxoSmithKline Plc - Overview; Exhibits129: GlaxoSmithKline Plc - Business segments; Exhibits130: GlaxoSmithKline Plc - Key news; Exhibits131: GlaxoSmithKline Plc - Key offerings; Exhibits132: GlaxoSmithKline Plc - Segment focus; Exhibits133: Lupin Ltd. - Overview; Exhibits134: Lupin Ltd. - Product / Service; Exhibits135: Lupin Ltd. - Key news; Exhibits136: Lupin Ltd. - Key offerings; Exhibits137: Myungmoon Pharm Co. Ltd. - Overview; Exhibits138: Myungmoon Pharm Co. Ltd. - Product / Service; Exhibits139: Myungmoon Pharm Co. Ltd. - Key offerings; Exhibits140: Novartis AG - Overview; Exhibits141: Novartis AG - Business segments; Exhibits142: Novartis AG - Key news; Exhibits143: Novartis AG - Key offerings; Exhibits144: Novartis AG - Segment focus; Exhibits145: Perrigo Co. Plc - Overview; Exhibits146: Perrigo Co. Plc - Business segments; Exhibits147: Perrigo Co. Plc - Key offerings; Exhibits148: Perrigo Co. Plc - Segment focus; Exhibits149: Prestige Consumer Healthcare Inc. - Overview; Exhibits150: Prestige Consumer Healthcare Inc. - Business segments; Exhibits151: Prestige Consumer Healthcare Inc. - Key offerings; Exhibits152: Prestige Consumer Healthcare Inc. - Segment focus; Exhibits153: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits154: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits155: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits156: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits157: Tivic Health Systems Inc. - Overview; Exhibits158: Tivic Health Systems Inc. - Product / Service; Exhibits159: Tivic Health Systems Inc. - Key offerings; Exhibits160: Viatris Inc. - Overview; Exhibits161: Viatris Inc. - Business segments; Exhibits162: Viatris Inc. - Key news; Exhibits163: Viatris Inc. - Key offerings; Exhibits164: Viatris Inc. - Segment focus; Exhibits165: WellSpring Pharmaceutical Corp. - Overview; Exhibits166: WellSpring Pharmaceutical Corp. - Product / Service; Exhibits167: WellSpring Pharmaceutical Corp. - Key offerings; Exhibits168: Zydus Lifesciences Ltd. - Overview; Exhibits169: Zydus Lifesciences Ltd. - Business segments; Exhibits170: Zydus Lifesciences Ltd. - Key news; Exhibits171: Zydus Lifesciences Ltd. - Key offerings; Exhibits172: Zydus Lifesciences Ltd. - Segment focus; Exhibits173: Inclusions checklist; Exhibits174: Exclusions checklist; Exhibits175: Currency conversion rates for US$; Exhibits176: Research methodology; Exhibits177: Information sources; Exhibits178: Data validation; Exhibits179: Validation techniques employed for market sizing; Exhibits180: Data synthesis; Exhibits181: 360 degree market analysis; Exhibits182: List of abbreviations